Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations

Journal of Endovascular Therapy

Volumn 19, Issue 6, 2012, Pages 788-796

  Spiliopoulos, Stavros ^a   Fragkos, George ^a   Katsanos, Konstantinos ^a   Diamantopoulos, Athanasios ^a   Karnabatidis, Dimitrios ^a   Siablis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Below the knee angioplasty; Bifurcation lesions; Critical limb ischemia; Drug eluting stent; Infrapopliteal artery; Occlusive disease; Primary stenting; Restenosis; Stenosis; Tibial artery

Indexed keywords

AGED; AMPUTATION; ARTERY DIAMETER; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CRITICAL LIMB ISCHEMIA; DRUG ELUTING STENT; FEMALE; HUMAN; INFRAPOPLITEAL BIFURCATION LESION; MALE; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; CHRONIC DISEASE; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 84871293974     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/JEVT-12-3993R.1     Document Type: Article

References (20)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S: S5-67.
2. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453-460. (Pubitemid 46349954)
3. Lee MS, Finch W. Stenting techniques for patients with bifurcation coronary artery disease. Rev Cardiovasc Med. 2011; 12(4):231-239.
4. Tamura T, Kimura T, Morimoto T, et al. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach. Euro-Intervention. 2011;7:588-596.
5. Sacks D, Marinelli DL, Martin LG, et al. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14(9 Pt 2):S395-404.
6. Peregrin JH, Koznar B, Kovac J, et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010;33:720-725.
7. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-1150.
8. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011;18:1-12.
9. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
10. Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011; 32:2274-2281.
11. Karnabatidis D, Spiliopoulos S, Katsanos K, et al. Below-the-knee drug-eluting stents and drug-coated balloons. Exp Rev Med Dev. 2012;9:85-94.
12. Katsanos K, Spiliopoulos S, Krokidis M, et al. Does below-the-knee placement of drug eluting stents improve clinical outcomes? J Cardiovasc Surg (Torino). 2012;53:195-203.
13. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-1249. (Pubitemid 38372783)
14. Steigen TK, Maeng M, Wiseth R, et al. Randomized study of simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114:1955-1961. (Pubitemid 44665390)
15. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv. 2006;68:793-798. (Pubitemid 44721107)
16. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006;2:169-174.
17. Athappan G, Ponniah T, Jeyaseelan L. True coronary bifurcation lesions: meta-analysis and review of literature. J Cardiovasc Med (Hagerstown). 2010;11:103-110.
18. Assali AR, Assa HV, Ben-Dor I, et al. Drug-eluting stents in bifurcations lesions: to stent one branch or both. Catheter Cardiovasc Interv. 2006;68:891-896. (Pubitemid 44847095)
19. Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012;19:571-580.
20. Varcoe RL. Commentary: Drug-eluting balloons: are they the magic bullet? J Endovasc Ther. 2012;19:581-584.